Global Swine Vaccines Supply, Demand and Key Producers, 2025-2031

Description

The global Swine Vaccines market size is expected to reach $ 2077 million by 2031, rising at a market growth of 3.9% CAGR during the forecast period (2025-2031).

In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.,Swine vaccines are biological preparations designed to prevent and control infectious diseases in pigs by stimulating specific antibody and cellular immune responses. They are classified into inactivated, live attenuated, subunit, recombinant, and nucleic acid vaccines, widely applied against key swine diseases such as classical swine fever, PRRS, pseudorabies, foot-and-mouth disease, porcine circovirus, and mycoplasmal pneumonia. As modern pig farming shifts toward intensive and high-efficiency operations, swine vaccines have become essential tools for improving herd health, enhancing productivity, ensuring food safety, and safeguarding public health. The industry’s innovation trend is evolving from traditional prophylaxis to precision immunization and multivalent combination vaccine technologies. In 2024, global Swine vaccines production reached approximately 12.56 billion units , with an average global market price of around US$ 123 k unit.The average gross profit margin for this product is 70%.

The global swine vaccine market is experiencing structural growth opportunities. The ongoing threat of highly pathogenic diseases such as African swine fever and PRRS has prompted governments to strengthen animal health infrastructure, while companies increasingly prioritize preventive immunization over therapeutic solutions. Meanwhile, advances in biotechnology and genetic engineering are accelerating the commercialization of next-generation vaccines—including DNA, mRNA, and adjuvant-optimized formulations—creating new growth engines for global animal health leaders. In regions such as China, Southeast Asia, and Latin America, rapid consolidation of pig farming is boosting demand for high-safety, broad-spectrum vaccines, marking a new phase of technology-driven and brand-oriented competition.

Despite its strong outlook, the industry faces multiple risks including regulatory complexity, technological barriers, and market volatility. Stricter vaccine approval procedures—especially for recombinant and genetic vaccines—extend product launch timelines and increase R&D costs, limiting smaller firms’ participation. In addition, fluctuating raw material prices, cold-chain logistics requirements, and unpredictable outbreaks create operational uncertainty. The circulation of unlicensed vaccines and inconsistent immunization practices in certain regions further undermine market integrity and trust.

Demand from pig producers is shifting from “disease prevention” toward “integrated herd health management.” Large-scale farms and agri-food conglomerates are adopting comprehensive immunization solutions, accelerating the adoption of multivalent and precision vaccination systems. Growing consumer concerns over pork safety and traceability are reinforcing the need for regulated vaccination programs. Future market evolution will emphasize the integration of immunization monitoring, digital farming, and biosecurity management, fostering a value-driven, data-linked vaccine ecosystem.

The upstream supply chain of swine vaccines includes antigens, culture media, adjuvants, stabilizers, and packaging materials. Optimizing antigen production and virus culture systems remains key to cost control and batch consistency. Some premium vaccine components—such as advanced cell media and imported adjuvants—still rely on international suppliers, posing supply chain risks. However, with advances in domestic fermentation, synthetic biology, and formulation technologies, local substitution is accelerating. High-purity materials and customized bioreactor systems are expected to become crucial differentiators for vaccine manufacturers.

This report studies the global Swine Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Swine Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Swine Vaccines total production and demand, 2020-2031, (M Doses)
Global Swine Vaccines total production value, 2020-2031, (USD Million)
Global Swine Vaccines production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (M Doses), (based on production site)
Global Swine Vaccines consumption by region & country, CAGR, 2020-2031 & (M Doses)
U.S. VS China: Swine Vaccines domestic production, consumption, key domestic manufacturers and share
Global Swine Vaccines production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (M Doses)
Global Swine Vaccines production by Type, production, value, CAGR, 2020-2031, (USD Million) & (M Doses)
Global Swine Vaccines production by Application, production, value, CAGR, 2020-2031, (USD Million) & (M Doses)
This report profiles key players in the global Swine Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.

Global Swine Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Swine Vaccines Market, Segmentation by Type:
    CSF Vaccines
    FMD Vaccines
    Porcine Circovirus Vaccines
    PRRS Vaccines
    Others

Global Swine Vaccines Market, Segmentation by Application:
    Government Tender
    Market Sales

Companies Profiled:
    Merck
    Boehringer Ingelheim
    Jinyu Bio-Technology
    CAHIC
    Tecon
    Zoetis
    Ceva
    Hile Bio
    Chopper Biology
    WINSUN
    Hipra
    Ringpu Biology
    ChengDu Tecbond
    DHN
    CAVAC
    Virbac
    HVRI
    Bioveta
    Cavet Bio
    BIGVET Biotech

Key Questions Answered:
1. How big is the global Swine Vaccines market?
2. What is the demand of the global Swine Vaccines market?
3. What is the year over year growth of the global Swine Vaccines market?
4. What is the production and production value of the global Swine Vaccines market?
5. Who are the key producers in the global Swine Vaccines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Swine Vaccines Introduction
    1.2 World Swine Vaccines Supply & Forecast
        1.2.1 World Swine Vaccines Production Value (2020 & 2024 & 2031)
        1.2.2 World Swine Vaccines Production (2020-2031)
        1.2.3 World Swine Vaccines Pricing Trends (2020-2031)
    1.3 World Swine Vaccines Production by Region (Based on Production Site)
        1.3.1 World Swine Vaccines Production Value by Region (2020-2031)
        1.3.2 World Swine Vaccines Production by Region (2020-2031)
        1.3.3 World Swine Vaccines Average Price by Region (2020-2031)
        1.3.4 North America Swine Vaccines Production (2020-2031)
        1.3.5 Europe Swine Vaccines Production (2020-2031)
        1.3.6 China Swine Vaccines Production (2020-2031)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Swine Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Swine Vaccines Major Market Trends

2 Demand Summary
    2.1 World Swine Vaccines Demand (2020-2031)
    2.2 World Swine Vaccines Consumption by Region
        2.2.1 World Swine Vaccines Consumption by Region (2020-2025)
        2.2.2 World Swine Vaccines Consumption Forecast by Region (2026-2031)
    2.3 United States Swine Vaccines Consumption (2020-2031)
    2.4 China Swine Vaccines Consumption (2020-2031)
    2.5 Europe Swine Vaccines Consumption (2020-2031)
    2.6 Japan Swine Vaccines Consumption (2020-2031)
    2.7 South Korea Swine Vaccines Consumption (2020-2031)
    2.8 ASEAN Swine Vaccines Consumption (2020-2031)
    2.9 India Swine Vaccines Consumption (2020-2031)

3 World Manufacturers Competitive Analysis
    3.1 World Swine Vaccines Production Value by Manufacturer (2020-2025)
    3.2 World Swine Vaccines Production by Manufacturer (2020-2025)
    3.3 World Swine Vaccines Average Price by Manufacturer (2020-2025)
    3.4 Swine Vaccines Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Swine Vaccines Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Swine Vaccines in 2024
        3.5.3 Global Concentration Ratios (CR8) for Swine Vaccines in 2024
    3.6 Swine Vaccines Market: Overall Company Footprint Analysis
        3.6.1 Swine Vaccines Market: Region Footprint
        3.6.2 Swine Vaccines Market: Company Product Type Footprint
        3.6.3 Swine Vaccines Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Swine Vaccines Production Value Comparison
        4.1.1 United States VS China: Swine Vaccines Production Value Comparison (2020 & 2024 & 2031)
        4.1.2 United States VS China: Swine Vaccines Production Value Market Share Comparison (2020 & 2024 & 2031)
    4.2 United States VS China: Swine Vaccines Production Comparison
        4.2.1 United States VS China: Swine Vaccines Production Comparison (2020 & 2024 & 2031)
        4.2.2 United States VS China: Swine Vaccines Production Market Share Comparison (2020 & 2024 & 2031)
    4.3 United States VS China: Swine Vaccines Consumption Comparison
        4.3.1 United States VS China: Swine Vaccines Consumption Comparison (2020 & 2024 & 2031)
        4.3.2 United States VS China: Swine Vaccines Consumption Market Share Comparison (2020 & 2024 & 2031)
    4.4 United States Based Swine Vaccines Manufacturers and Market Share, 2020-2025
        4.4.1 United States Based Swine Vaccines Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Swine Vaccines Production Value (2020-2025)
        4.4.3 United States Based Manufacturers Swine Vaccines Production (2020-2025)
    4.5 China Based Swine Vaccines Manufacturers and Market Share
        4.5.1 China Based Swine Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Swine Vaccines Production Value (2020-2025)
        4.5.3 China Based Manufacturers Swine Vaccines Production (2020-2025)
    4.6 Rest of World Based Swine Vaccines Manufacturers and Market Share, 2020-2025
        4.6.1 Rest of World Based Swine Vaccines Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Swine Vaccines Production Value (2020-2025)
        4.6.3 Rest of World Based Manufacturers Swine Vaccines Production (2020-2025)

5 Market Analysis by Type
    5.1 World Swine Vaccines Market Size Overview by Type: 2020 VS 2024 VS 2031
    5.2 Segment Introduction by Type
        5.2.1 CSF Vaccines
        5.2.2 FMD Vaccines
        5.2.3 Porcine Circovirus Vaccines
        5.2.4 PRRS Vaccines
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Swine Vaccines Production by Type (2020-2031)
        5.3.2 World Swine Vaccines Production Value by Type (2020-2031)
        5.3.3 World Swine Vaccines Average Price by Type (2020-2031)

6 Market Analysis by Application
    6.1 World Swine Vaccines Market Size Overview by Application: 2020 VS 2024 VS 2031
    6.2 Segment Introduction by Application
        6.2.1 Government Tender
        6.2.2 Market Sales
    6.3 Market Segment by Application
        6.3.1 World Swine Vaccines Production by Application (2020-2031)
        6.3.2 World Swine Vaccines Production Value by Application (2020-2031)
        6.3.3 World Swine Vaccines Average Price by Application (2020-2031)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck Swine Vaccines Product and Services
        7.1.4 Merck Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Boehringer Ingelheim
        7.2.1 Boehringer Ingelheim Details
        7.2.2 Boehringer Ingelheim Major Business
        7.2.3 Boehringer Ingelheim Swine Vaccines Product and Services
        7.2.4 Boehringer Ingelheim Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.2.5 Boehringer Ingelheim Recent Developments/Updates
        7.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.3 Jinyu Bio-Technology
        7.3.1 Jinyu Bio-Technology Details
        7.3.2 Jinyu Bio-Technology Major Business
        7.3.3 Jinyu Bio-Technology Swine Vaccines Product and Services
        7.3.4 Jinyu Bio-Technology Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.3.5 Jinyu Bio-Technology Recent Developments/Updates
        7.3.6 Jinyu Bio-Technology Competitive Strengths & Weaknesses
    7.4 CAHIC
        7.4.1 CAHIC Details
        7.4.2 CAHIC Major Business
        7.4.3 CAHIC Swine Vaccines Product and Services
        7.4.4 CAHIC Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.4.5 CAHIC Recent Developments/Updates
        7.4.6 CAHIC Competitive Strengths & Weaknesses
    7.5 Tecon
        7.5.1 Tecon Details
        7.5.2 Tecon Major Business
        7.5.3 Tecon Swine Vaccines Product and Services
        7.5.4 Tecon Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.5.5 Tecon Recent Developments/Updates
        7.5.6 Tecon Competitive Strengths & Weaknesses
    7.6 Zoetis
        7.6.1 Zoetis Details
        7.6.2 Zoetis Major Business
        7.6.3 Zoetis Swine Vaccines Product and Services
        7.6.4 Zoetis Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.6.5 Zoetis Recent Developments/Updates
        7.6.6 Zoetis Competitive Strengths & Weaknesses
    7.7 Ceva
        7.7.1 Ceva Details
        7.7.2 Ceva Major Business
        7.7.3 Ceva Swine Vaccines Product and Services
        7.7.4 Ceva Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.7.5 Ceva Recent Developments/Updates
        7.7.6 Ceva Competitive Strengths & Weaknesses
    7.8 Hile Bio
        7.8.1 Hile Bio Details
        7.8.2 Hile Bio Major Business
        7.8.3 Hile Bio Swine Vaccines Product and Services
        7.8.4 Hile Bio Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.8.5 Hile Bio Recent Developments/Updates
        7.8.6 Hile Bio Competitive Strengths & Weaknesses
    7.9 Chopper Biology
        7.9.1 Chopper Biology Details
        7.9.2 Chopper Biology Major Business
        7.9.3 Chopper Biology Swine Vaccines Product and Services
        7.9.4 Chopper Biology Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.9.5 Chopper Biology Recent Developments/Updates
        7.9.6 Chopper Biology Competitive Strengths & Weaknesses
    7.10 WINSUN
        7.10.1 WINSUN Details
        7.10.2 WINSUN Major Business
        7.10.3 WINSUN Swine Vaccines Product and Services
        7.10.4 WINSUN Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.10.5 WINSUN Recent Developments/Updates
        7.10.6 WINSUN Competitive Strengths & Weaknesses
    7.11 Hipra
        7.11.1 Hipra Details
        7.11.2 Hipra Major Business
        7.11.3 Hipra Swine Vaccines Product and Services
        7.11.4 Hipra Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.11.5 Hipra Recent Developments/Updates
        7.11.6 Hipra Competitive Strengths & Weaknesses
    7.12 Ringpu Biology
        7.12.1 Ringpu Biology Details
        7.12.2 Ringpu Biology Major Business
        7.12.3 Ringpu Biology Swine Vaccines Product and Services
        7.12.4 Ringpu Biology Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.12.5 Ringpu Biology Recent Developments/Updates
        7.12.6 Ringpu Biology Competitive Strengths & Weaknesses
    7.13 ChengDu Tecbond
        7.13.1 ChengDu Tecbond Details
        7.13.2 ChengDu Tecbond Major Business
        7.13.3 ChengDu Tecbond Swine Vaccines Product and Services
        7.13.4 ChengDu Tecbond Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.13.5 ChengDu Tecbond Recent Developments/Updates
        7.13.6 ChengDu Tecbond Competitive Strengths & Weaknesses
    7.14 DHN
        7.14.1 DHN Details
        7.14.2 DHN Major Business
        7.14.3 DHN Swine Vaccines Product and Services
        7.14.4 DHN Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.14.5 DHN Recent Developments/Updates
        7.14.6 DHN Competitive Strengths & Weaknesses
    7.15 CAVAC
        7.15.1 CAVAC Details
        7.15.2 CAVAC Major Business
        7.15.3 CAVAC Swine Vaccines Product and Services
        7.15.4 CAVAC Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.15.5 CAVAC Recent Developments/Updates
        7.15.6 CAVAC Competitive Strengths & Weaknesses
    7.16 Virbac
        7.16.1 Virbac Details
        7.16.2 Virbac Major Business
        7.16.3 Virbac Swine Vaccines Product and Services
        7.16.4 Virbac Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.16.5 Virbac Recent Developments/Updates
        7.16.6 Virbac Competitive Strengths & Weaknesses
    7.17 HVRI
        7.17.1 HVRI Details
        7.17.2 HVRI Major Business
        7.17.3 HVRI Swine Vaccines Product and Services
        7.17.4 HVRI Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.17.5 HVRI Recent Developments/Updates
        7.17.6 HVRI Competitive Strengths & Weaknesses
    7.18 Bioveta
        7.18.1 Bioveta Details
        7.18.2 Bioveta Major Business
        7.18.3 Bioveta Swine Vaccines Product and Services
        7.18.4 Bioveta Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.18.5 Bioveta Recent Developments/Updates
        7.18.6 Bioveta Competitive Strengths & Weaknesses
    7.19 Cavet Bio
        7.19.1 Cavet Bio Details
        7.19.2 Cavet Bio Major Business
        7.19.3 Cavet Bio Swine Vaccines Product and Services
        7.19.4 Cavet Bio Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.19.5 Cavet Bio Recent Developments/Updates
        7.19.6 Cavet Bio Competitive Strengths & Weaknesses
    7.20 BIGVET Biotech
        7.20.1 BIGVET Biotech Details
        7.20.2 BIGVET Biotech Major Business
        7.20.3 BIGVET Biotech Swine Vaccines Product and Services
        7.20.4 BIGVET Biotech Swine Vaccines Production, Price, Value, Gross Margin and Market Share (2020-2025)
        7.20.5 BIGVET Biotech Recent Developments/Updates
        7.20.6 BIGVET Biotech Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Swine Vaccines Industry Chain
    8.2 Swine Vaccines Upstream Analysis
        8.2.1 Swine Vaccines Core Raw Materials
        8.2.2 Main Manufacturers of Swine Vaccines Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Swine Vaccines Production Mode
    8.6 Swine Vaccines Procurement Model
    8.7 Swine Vaccines Industry Sales Model and Sales Channels
        8.7.1 Swine Vaccines Sales Model
        8.7.2 Swine Vaccines Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Swine Vaccines Production Value by Region (2020, 2024 and 2031) & (USD Million)
 Table 2. World Swine Vaccines Production Value by Region (2020-2025) & (USD Million)
 Table 3. World Swine Vaccines Production Value by Region (2026-2031) & (USD Million)
 Table 4. World Swine Vaccines Production Value Market Share by Region (2020-2025)
 Table 5. World Swine Vaccines Production Value Market Share by Region (2026-2031)
 Table 6. World Swine Vaccines Production by Region (2020-2025) & (M Doses)
 Table 7. World Swine Vaccines Production by Region (2026-2031) & (M Doses)
 Table 8. World Swine Vaccines Production Market Share by Region (2020-2025)
 Table 9. World Swine Vaccines Production Market Share by Region (2026-2031)
 Table 10. World Swine Vaccines Average Price by Region (2020-2025) & (USD/K Doses)
 Table 11. World Swine Vaccines Average Price by Region (2026-2031) & (USD/K Doses)
 Table 12. Swine Vaccines Major Market Trends
 Table 13. World Swine Vaccines Consumption Growth Rate Forecast by Region (2020 & 2024 & 2031) & (M Doses)
 Table 14. World Swine Vaccines Consumption by Region (2020-2025) & (M Doses)
 Table 15. World Swine Vaccines Consumption Forecast by Region (2026-2031) & (M Doses)
 Table 16. World Swine Vaccines Production Value by Manufacturer (2020-2025) & (USD Million)
 Table 17. Production Value Market Share of Key Swine Vaccines Producers in 2024
 Table 18. World Swine Vaccines Production by Manufacturer (2020-2025) & (M Doses)
 Table 19. Production Market Share of Key Swine Vaccines Producers in 2024
 Table 20. World Swine Vaccines Average Price by Manufacturer (2020-2025) & (USD/K Doses)
 Table 21. Global Swine Vaccines Company Evaluation Quadrant
 Table 22. World Swine Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2024
 Table 23. Head Office and Swine Vaccines Production Site of Key Manufacturer
 Table 24. Swine Vaccines Market: Company Product Type Footprint
 Table 25. Swine Vaccines Market: Company Product Application Footprint
 Table 26. Swine Vaccines Competitive Factors
 Table 27. Swine Vaccines New Entrant and Capacity Expansion Plans
 Table 28. Swine Vaccines Mergers & Acquisitions Activity
 Table 29. United States VS China Swine Vaccines Production Value Comparison, (2020 & 2024 & 2031) & (USD Million)
 Table 30. United States VS China Swine Vaccines Production Comparison, (2020 & 2024 & 2031) & (M Doses)
 Table 31. United States VS China Swine Vaccines Consumption Comparison, (2020 & 2024 & 2031) & (M Doses)
 Table 32. United States Based Swine Vaccines Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Swine Vaccines Production Value, (2020-2025) & (USD Million)
 Table 34. United States Based Manufacturers Swine Vaccines Production Value Market Share (2020-2025)
 Table 35. United States Based Manufacturers Swine Vaccines Production (2020-2025) & (M Doses)
 Table 36. United States Based Manufacturers Swine Vaccines Production Market Share (2020-2025)
 Table 37. China Based Swine Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Swine Vaccines Production Value, (2020-2025) & (USD Million)
 Table 39. China Based Manufacturers Swine Vaccines Production Value Market Share (2020-2025)
 Table 40. China Based Manufacturers Swine Vaccines Production, (2020-2025) & (M Doses)
 Table 41. China Based Manufacturers Swine Vaccines Production Market Share (2020-2025)
 Table 42. Rest of World Based Swine Vaccines Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Swine Vaccines Production Value, (2020-2025) & (USD Million)
 Table 44. Rest of World Based Manufacturers Swine Vaccines Production Value Market Share (2020-2025)
 Table 45. Rest of World Based Manufacturers Swine Vaccines Production, (2020-2025) & (M Doses)
 Table 46. Rest of World Based Manufacturers Swine Vaccines Production Market Share (2020-2025)
 Table 47. World Swine Vaccines Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 48. World Swine Vaccines Production by Type (2020-2025) & (M Doses)
 Table 49. World Swine Vaccines Production by Type (2026-2031) & (M Doses)
 Table 50. World Swine Vaccines Production Value by Type (2020-2025) & (USD Million)
 Table 51. World Swine Vaccines Production Value by Type (2026-2031) & (USD Million)
 Table 52. World Swine Vaccines Average Price by Type (2020-2025) & (USD/K Doses)
 Table 53. World Swine Vaccines Average Price by Type (2026-2031) & (USD/K Doses)
 Table 54. World Swine Vaccines Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 55. World Swine Vaccines Production by Application (2020-2025) & (M Doses)
 Table 56. World Swine Vaccines Production by Application (2026-2031) & (M Doses)
 Table 57. World Swine Vaccines Production Value by Application (2020-2025) & (USD Million)
 Table 58. World Swine Vaccines Production Value by Application (2026-2031) & (USD Million)
 Table 59. World Swine Vaccines Average Price by Application (2020-2025) & (USD/K Doses)
 Table 60. World Swine Vaccines Average Price by Application (2026-2031) & (USD/K Doses)
 Table 61. Merck Basic Information, Manufacturing Base and Competitors
 Table 62. Merck Major Business
 Table 63. Merck Swine Vaccines Product and Services
 Table 64. Merck Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 65. Merck Recent Developments/Updates
 Table 66. Merck Competitive Strengths & Weaknesses
 Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
 Table 68. Boehringer Ingelheim Major Business
 Table 69. Boehringer Ingelheim Swine Vaccines Product and Services
 Table 70. Boehringer Ingelheim Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 71. Boehringer Ingelheim Recent Developments/Updates
 Table 72. Boehringer Ingelheim Competitive Strengths & Weaknesses
 Table 73. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
 Table 74. Jinyu Bio-Technology Major Business
 Table 75. Jinyu Bio-Technology Swine Vaccines Product and Services
 Table 76. Jinyu Bio-Technology Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 77. Jinyu Bio-Technology Recent Developments/Updates
 Table 78. Jinyu Bio-Technology Competitive Strengths & Weaknesses
 Table 79. CAHIC Basic Information, Manufacturing Base and Competitors
 Table 80. CAHIC Major Business
 Table 81. CAHIC Swine Vaccines Product and Services
 Table 82. CAHIC Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. CAHIC Recent Developments/Updates
 Table 84. CAHIC Competitive Strengths & Weaknesses
 Table 85. Tecon Basic Information, Manufacturing Base and Competitors
 Table 86. Tecon Major Business
 Table 87. Tecon Swine Vaccines Product and Services
 Table 88. Tecon Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 89. Tecon Recent Developments/Updates
 Table 90. Tecon Competitive Strengths & Weaknesses
 Table 91. Zoetis Basic Information, Manufacturing Base and Competitors
 Table 92. Zoetis Major Business
 Table 93. Zoetis Swine Vaccines Product and Services
 Table 94. Zoetis Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 95. Zoetis Recent Developments/Updates
 Table 96. Zoetis Competitive Strengths & Weaknesses
 Table 97. Ceva Basic Information, Manufacturing Base and Competitors
 Table 98. Ceva Major Business
 Table 99. Ceva Swine Vaccines Product and Services
 Table 100. Ceva Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 101. Ceva Recent Developments/Updates
 Table 102. Ceva Competitive Strengths & Weaknesses
 Table 103. Hile Bio Basic Information, Manufacturing Base and Competitors
 Table 104. Hile Bio Major Business
 Table 105. Hile Bio Swine Vaccines Product and Services
 Table 106. Hile Bio Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 107. Hile Bio Recent Developments/Updates
 Table 108. Hile Bio Competitive Strengths & Weaknesses
 Table 109. Chopper Biology Basic Information, Manufacturing Base and Competitors
 Table 110. Chopper Biology Major Business
 Table 111. Chopper Biology Swine Vaccines Product and Services
 Table 112. Chopper Biology Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 113. Chopper Biology Recent Developments/Updates
 Table 114. Chopper Biology Competitive Strengths & Weaknesses
 Table 115. WINSUN Basic Information, Manufacturing Base and Competitors
 Table 116. WINSUN Major Business
 Table 117. WINSUN Swine Vaccines Product and Services
 Table 118. WINSUN Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 119. WINSUN Recent Developments/Updates
 Table 120. WINSUN Competitive Strengths & Weaknesses
 Table 121. Hipra Basic Information, Manufacturing Base and Competitors
 Table 122. Hipra Major Business
 Table 123. Hipra Swine Vaccines Product and Services
 Table 124. Hipra Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 125. Hipra Recent Developments/Updates
 Table 126. Hipra Competitive Strengths & Weaknesses
 Table 127. Ringpu Biology Basic Information, Manufacturing Base and Competitors
 Table 128. Ringpu Biology Major Business
 Table 129. Ringpu Biology Swine Vaccines Product and Services
 Table 130. Ringpu Biology Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 131. Ringpu Biology Recent Developments/Updates
 Table 132. Ringpu Biology Competitive Strengths & Weaknesses
 Table 133. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
 Table 134. ChengDu Tecbond Major Business
 Table 135. ChengDu Tecbond Swine Vaccines Product and Services
 Table 136. ChengDu Tecbond Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 137. ChengDu Tecbond Recent Developments/Updates
 Table 138. ChengDu Tecbond Competitive Strengths & Weaknesses
 Table 139. DHN Basic Information, Manufacturing Base and Competitors
 Table 140. DHN Major Business
 Table 141. DHN Swine Vaccines Product and Services
 Table 142. DHN Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 143. DHN Recent Developments/Updates
 Table 144. DHN Competitive Strengths & Weaknesses
 Table 145. CAVAC Basic Information, Manufacturing Base and Competitors
 Table 146. CAVAC Major Business
 Table 147. CAVAC Swine Vaccines Product and Services
 Table 148. CAVAC Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 149. CAVAC Recent Developments/Updates
 Table 150. CAVAC Competitive Strengths & Weaknesses
 Table 151. Virbac Basic Information, Manufacturing Base and Competitors
 Table 152. Virbac Major Business
 Table 153. Virbac Swine Vaccines Product and Services
 Table 154. Virbac Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 155. Virbac Recent Developments/Updates
 Table 156. Virbac Competitive Strengths & Weaknesses
 Table 157. HVRI Basic Information, Manufacturing Base and Competitors
 Table 158. HVRI Major Business
 Table 159. HVRI Swine Vaccines Product and Services
 Table 160. HVRI Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 161. HVRI Recent Developments/Updates
 Table 162. HVRI Competitive Strengths & Weaknesses
 Table 163. Bioveta Basic Information, Manufacturing Base and Competitors
 Table 164. Bioveta Major Business
 Table 165. Bioveta Swine Vaccines Product and Services
 Table 166. Bioveta Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 167. Bioveta Recent Developments/Updates
 Table 168. Bioveta Competitive Strengths & Weaknesses
 Table 169. Cavet Bio Basic Information, Manufacturing Base and Competitors
 Table 170. Cavet Bio Major Business
 Table 171. Cavet Bio Swine Vaccines Product and Services
 Table 172. Cavet Bio Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 173. Cavet Bio Recent Developments/Updates
 Table 174. Cavet Bio Competitive Strengths & Weaknesses
 Table 175. BIGVET Biotech Basic Information, Manufacturing Base and Competitors
 Table 176. BIGVET Biotech Major Business
 Table 177. BIGVET Biotech Swine Vaccines Product and Services
 Table 178. BIGVET Biotech Swine Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
 Table 179. BIGVET Biotech Recent Developments/Updates
 Table 180. BIGVET Biotech Competitive Strengths & Weaknesses
 Table 181. Global Key Players of Swine Vaccines Upstream (Raw Materials)
 Table 182. Global Swine Vaccines Typical Customers
 Table 183. Swine Vaccines Typical Distributors


List of Figures
 Figure 1. Swine Vaccines Picture
 Figure 2. World Swine Vaccines Production Value: 2020 & 2024 & 2031, (USD Million)
 Figure 3. World Swine Vaccines Production Value and Forecast (2020-2031) & (USD Million)
 Figure 4. World Swine Vaccines Production (2020-2031) & (M Doses)
 Figure 5. World Swine Vaccines Average Price (2020-2031) & (USD/K Doses)
 Figure 6. World Swine Vaccines Production Value Market Share by Region (2020-2031)
 Figure 7. World Swine Vaccines Production Market Share by Region (2020-2031)
 Figure 8. North America Swine Vaccines Production (2020-2031) & (M Doses)
 Figure 9. Europe Swine Vaccines Production (2020-2031) & (M Doses)
 Figure 10. China Swine Vaccines Production (2020-2031) & (M Doses)
 Figure 11. Swine Vaccines Market Drivers
 Figure 12. Factors Affecting Demand
 Figure 13. World Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 14. World Swine Vaccines Consumption Market Share by Region (2020-2031)
 Figure 15. United States Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 16. China Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 17. Europe Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 18. Japan Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 19. South Korea Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 20. ASEAN Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 21. India Swine Vaccines Consumption (2020-2031) & (M Doses)
 Figure 22. Producer Shipments of Swine Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
 Figure 23. Global Four-firm Concentration Ratios (CR4) for Swine Vaccines Markets in 2024
 Figure 24. Global Four-firm Concentration Ratios (CR8) for Swine Vaccines Markets in 2024
 Figure 25. United States VS China: Swine Vaccines Production Value Market Share Comparison (2020 & 2024 & 2031)
 Figure 26. United States VS China: Swine Vaccines Production Market Share Comparison (2020 & 2024 & 2031)
 Figure 27. United States VS China: Swine Vaccines Consumption Market Share Comparison (2020 & 2024 & 2031)
 Figure 28. United States Based Manufacturers Swine Vaccines Production Market Share 2024
 Figure 29. China Based Manufacturers Swine Vaccines Production Market Share 2024
 Figure 30. Rest of World Based Manufacturers Swine Vaccines Production Market Share 2024
 Figure 31. World Swine Vaccines Production Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 32. World Swine Vaccines Production Value Market Share by Type in 2024
 Figure 33. CSF Vaccines
 Figure 34. FMD Vaccines
 Figure 35. Porcine Circovirus Vaccines
 Figure 36. PRRS Vaccines
 Figure 37. Others
 Figure 38. World Swine Vaccines Production Market Share by Type (2020-2031)
 Figure 39. World Swine Vaccines Production Value Market Share by Type (2020-2031)
 Figure 40. World Swine Vaccines Average Price by Type (2020-2031) & (USD/K Doses)
 Figure 41. World Swine Vaccines Production Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 42. World Swine Vaccines Production Value Market Share by Application in 2024
 Figure 43. Government Tender
 Figure 44. Market Sales
 Figure 45. World Swine Vaccines Production Market Share by Application (2020-2031)
 Figure 46. World Swine Vaccines Production Value Market Share by Application (2020-2031)
 Figure 47. World Swine Vaccines Average Price by Application (2020-2031) & (USD/K Doses)
 Figure 48. Swine Vaccines Industry Chain
 Figure 49. Swine Vaccines Procurement Model
 Figure 50. Swine Vaccines Sales Model
 Figure 51. Swine Vaccines Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Companies Mentioned

Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Cavet Bio
BIGVET Biotech